Fennec Pharmaceuticals Inc. · Brief

Next report

8 days

Nov 12 · after closeest.Q3 FY26

Expected move

No implied move.

5 reportsHistory

0 of 5≥ implied

Aug 4 '23±12.8%▲+0.25%×0.02

Nov 6 '23±32.8%▲+2.51%×0.08

Mar 25 '24±36.6%▼−1.00%×0.03

Mar 10 '25±30.1%▲+4.75%×0.16

Q1 FY26±48.6%▲+2.49%×0.05

quarterimplied−50%0+50%realized×

Q1 FY26±48.6%▲+2.49%×0.05

Mar '25±30.1%▲+4.75%×0.16

Mar '24±36.6%▼−1.00%×0.03

Nov '23±32.8%▲+2.51%×0.08

Aug '23±12.8%▲+0.25%×0.02

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 12 report · est.

Bull2 of 3

104managers reporting a position in the latest quarterly filings13F · Jun 30 '26

2 of 19of the largest reporting managers cut their stake last quarter13F · Jun 30 '26

Bear2 of 3

3tracked funds holding FENCN-PORT · Aug 31 '26

0.01%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Oct 12 '26once per report · top 2 per case

FENC report session

No linked exposure.

Oct 29impliedImplied move: ±39.6% into Nov 12 earnings (Oct 29 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.